Attributes | Values |
---|
rdf:type
| |
Description
| - Natriuretic peptide (NP) increased early in patients with left ventricular (LV) systolic dysfunction, but early markers of HF development in patients with obesity and hypertension (HT) and LV diastolic dysfunction (DD) are already not very well known. Methods: 118 (56 years, 62 men) consecutive HT pts (stage I and II) with obesity using the value of 30 of body mass Index (BMI) as a cut-off was divided into two groups: A with BMI<30 (n = 56) and B with BMI>30 (n = 62). LV function was assessed by natriuretic peptide plasma levels (BNP, NT pro BNP). Relative wall thickness, cardiac mass, LV volumes and ejection fraction, velocity of early and late diastolic LV filling maximal velocity (E, A), E/A ratio, deceleration E time from transmitral Doppler, and pulsed doppler tissue imaging of velocities of mitral annular movements (Sm, Em, Am) were calculated by echo. Results: Pts revealed normal systolic function of the LV and the same degrese of LVH (61,19 versus 63,4 g/m2,7).
- Natriuretic peptide (NP) increased early in patients with left ventricular (LV) systolic dysfunction, but early markers of HF development in patients with obesity and hypertension (HT) and LV diastolic dysfunction (DD) are already not very well known. Methods: 118 (56 years, 62 men) consecutive HT pts (stage I and II) with obesity using the value of 30 of body mass Index (BMI) as a cut-off was divided into two groups: A with BMI<30 (n = 56) and B with BMI>30 (n = 62). LV function was assessed by natriuretic peptide plasma levels (BNP, NT pro BNP). Relative wall thickness, cardiac mass, LV volumes and ejection fraction, velocity of early and late diastolic LV filling maximal velocity (E, A), E/A ratio, deceleration E time from transmitral Doppler, and pulsed doppler tissue imaging of velocities of mitral annular movements (Sm, Em, Am) were calculated by echo. Results: Pts revealed normal systolic function of the LV and the same degrese of LVH (61,19 versus 63,4 g/m2,7). (en)
- Natriuretic peptide (NP) increased early in patients with left ventricular (LV) systolic dysfunction, but early markers of HF development in patients with obesity and hypertension (HT) and LV diastolic dysfunction (DD) are already not very well known. Methods: 118 (56 years, 62 men) consecutive HT pts (stage I and II) with obesity using the value of 30 of body mass Index (BMI) as a cut-off was divided into two groups: A with BMI<30 (n = 56) and B with BMI>30 (n = 62). LV function was assessed by natriuretic peptide plasma levels (BNP, NT pro BNP). Relative wall thickness, cardiac mass, LV volumes and ejection fraction, velocity of early and late diastolic LV filling maximal velocity (E, A), E/A ratio, deceleration E time from transmitral Doppler, and pulsed doppler tissue imaging of velocities of mitral annular movements (Sm, Em, Am) were calculated by echo. Results: Pts revealed normal systolic function of the LV and the same degrese of LVH (61,19 versus 63,4 g/m2,7). (cs)
|
Title
| - Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging
- Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging (en)
- Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging (cs)
|
skos:prefLabel
| - Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging
- Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging (en)
- Natriuretic Peptides As A Marker of Left Ventricular Diastolic Dysfunction in Patients With Obesity and Hypertension: Relationship With Doppler Tissue Imaging (cs)
|
skos:notation
| - RIV/00216224:14110/10:00046870!RIV11-MSM-14110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/10:00046870
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - hypertension natriuretic peptides (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| - Souček, Miroslav
- Špác, Jiří
- Němcová, Helena
|
http://linked.open...n/vavai/riv/zamer
| |
http://localhost/t...ganizacniJednotka
| |